Cargando…
Spexin-based galanin receptor 2 agonist improves renal injury in mice with type 2 diabetes
The spexin-based GALR2 agonist (NS200) is a novel drug, which has shown antidepressant and anxiolytic action in a recent experimental study. In this study, we investigated the effects of NS200 on renal injury in an animal model of type 2 diabetes. Eight-week-old diabetic db/db mice were administered...
Autores principales: | Cha, Jin Joo, Park, Boo Yeon, Yoon, Sung Gi, Park, Hye Jin, Yoo, Ji Ae, Ghee, Jung Yeon, Cha, Dae Ryong, Seong, Jae Young, Kang, Young Sun |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Taylor & Francis
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10543361/ https://www.ncbi.nlm.nih.gov/pubmed/37789932 http://dx.doi.org/10.1080/19768354.2023.2263067 |
Ejemplares similares
-
Spexin-Based Galanin Receptor Type 2 Agonist for Comorbid Mood Disorders and Abnormal Body Weight
por: Yun, Seongsik, et al.
Publicado: (2019) -
Development of Spexin-based Human Galanin Receptor Type II-Specific Agonists with Increased Stability in Serum and Anxiolytic Effect in Mice
por: Reyes-Alcaraz, Arfaxad, et al.
Publicado: (2016) -
Upregulation of VSIG4 in Type 2 Diabetic Kidney Disease
por: Han, Sang Youb, et al.
Publicado: (2022) -
SH3YL1 Protein Predicts Renal Outcomes in Patients with Type 2 Diabetes
por: Han, Sang Youb, et al.
Publicado: (2023) -
Spexin and a Novel Cichlid-Specific Spexin Paralog Both Inhibit FSH and LH Through a Specific Galanin Receptor (Galr2b) in Tilapia
por: Cohen, Yaron, et al.
Publicado: (2020)